Johnson & Johnson announced another recall of Tylenol products today.
This one’s a bit different from other production-related recalls that have plagued the company recently. The almost 9.3 million bottles of three Tylenol Cold Multi-Symptom products are being pulled due to a labeling issue — the front-of-the-bottle label didn’t disclose the small (less than 1% of the product) amount of alcohol present. The labels on the back of the bottle and on the packaging did disclose the ingredient, the WSJ reports. J&J says there’s no reason consumers shouldn’t use the products.
Moreover, the paper says, “The company has indicated more such actions are likely, as it tries to bring its manufacturing up to compliance under the watchful eye of regulators.” J&J has been reviewing its operations and that ongoing process is likely to lead to more recalls, the WSJ says.
Another result from that review: earlier this week, the WSJ reported that the company told drugstores and suppliers to return about 4.8 million bottles of children’s Benadryl and Motrin. Again, there weren’t any health problems associated with the products — which is why J&J says consumers can keep the drugs and continue to take them — but they were made at the company’s Fort Washington, Pa., plant before it was temporarily closed to address manufacturing deficiencies.
In the putting-it-back-on-the-shelves rather than taking-it-off-the-shelves category, J&J children’s medicines recalled in May are beginning to make their way back to drugstores.
Photo: Associated Press